Categories AlphaGraphs, Earnings, Technology

Outlook: Autodesk expects to see a jump in fiscal 2020 billings, revenue

Autodesk, Inc. (NASDAQ: ADSK) on Thursday reaffirmed its business outlook for the first quarter and fiscal year 2020 as it held its Investor Day celebrations at the Autodesk Gallery in San Francisco.

Autodesk CEO Andrew Anagnost said that “the strong momentum” at the end of fiscal 2019 “provided us with a great deal of confidence going into fiscal 2020.”

“With the business model transition effectively behind us, we’re looking forward to providing the investment community with additional details on how we will fuel sustainable growth in our fiscal 2020 and beyond,” he added.

Read our Earnings Coverage: Accenture Q2 results beat estimates

 

For the first quarter of fiscal 2020, Autodesk now expects revenue of $735-745 million, generating GAAP earnings of 6-10 cents per share and $0.44-0.48 in non-GAAP EPS.

Non-GAAP earnings for the quarter excludes $0.34 in stock-based compensation expenses, $0.07 in amortization of acquisition-related intangibles, $0.04 in acquisition-related costs, and a $0.07 gain related to GAAP-only tax charges.

Autodesk fourth quarter 2019 earnings snapshot
Autodesk Q4 2019 Earnings Infographic

For the full-year, total ARR is expected to be up 27-29% to hit $3.50-3.55 billion.

Billings are estimated to surge 50-53% to reach $4.05-4.15 billion, while revenue is touted to grow 26-28% to $3.25-3.30 billion.

For fiscal 2020, Autodesk expects GAAP earnings to be between $1.12 and $1.31 per share, while non-GAAP earnings is estimated to be $2.71-2.90 per share. Free cash flow in the year is estimated to hit about $1.35 billion.

For the year, Autodesk does not expect foreign currency exchange rates or hedge gains/losses to impact its revenue guidance materially.

 

 

 

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top